🇺🇸 FDA
Patent

US 11744885

Vaccines for recurrent respiratory papillomatosis and methods of using the same

granted A61KA61K2039/5254A61K2039/53

Quick answer

US patent 11744885 (Vaccines for recurrent respiratory papillomatosis and methods of using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K2039/5254, A61K2039/53, A61K2039/54, A61K2039/55538